Canadian Association Conducting Purple Challenge Campaign During PH Awareness Month
The Pulmonary Hypertension Association of Canada is conducting a Life in Purple Challenge this month as part of its efforts to mark November as Pulmonary Hypertension Awareness Month.
Pulmonary Hypertension Association of Canada Launches New Educational Campaign Targeting Medical Professionals for World Pulmonary Hypertension Day 2017
The Pulmonary Hypertension Association of Canada (PHA Canada) will mark the 6th annual World Pulmonary Hypertension Day on May 05, 2017 with the launch of Sometimes It’s PH, a new educational campaign targeting medical professionals. On May 05th, PHA Canada will release its new website featuring information on pulmonary hypertension (PH) including its signs and symptoms, risk factors, diagnosis, and treatment.
25 years later, Saskatoon woman thankful for second chance
A quarter century later, Sherry Duncan Paterson still remembers exactly what her husband Bob told her when she woke up. “When I was sick I was very blue and grey. And the first words my husband said to me were the best words I’ve ever heard, I think, in my whole life — ‘You’re so pink.’ And then I knew I would be okay.” She first felt something was wrong a few weeks after the birth of her second daughter. She was breathless just from climbi…
iPSCs Uncover Protective Pathways Against Carriers of BMPR2 Mutation
Contrary to what we learned in our high school biology classes, not all genetic diseases are easy to predict. Many of you may remember Punnett Squares, where we were able to determine the likelihood of a child having certain outcomes or diseases. While cystic fibrosis (CF) often is the pulmonary poster child of genetic disease, we’ve learned that pulmonary hypertension is far more complicated. For example, in cystic fibrosis, two parents who a…
Cord Blood Test Might Help Predict Fatal Lung Disease in Preemies
Findings published in the Journal of Pediatrics describe growth factors in cord blood that may identify premature infants at risk for bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) – an often fatal lung disease in which the vessels carrying blood from the heart to the lungs become narrowed and dysfunctional. Identifying these babies at birth would allow earlier interventions to prevent the disease that manifests in some pre…
Research Corner: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
In this issue of Research Corner, we will address questions regarding chronic thromboembolic pulmonary hypertension (CTEPH), which is classified as Group IV pulmonary hypertension.
Role of Stem Cells in Chronic Lung Diseases Revealed
A novel population of lung stem cells plays an important role in regulating the pulmonary microvasculature — the network of tiny blood vessels where oxygen and carbon dioxide exchange takes place.
Special Stem Cells May Participate in Pulmonary Hypertension Lung Repair, Study Reports
A small group of stem cells may help repair the lungs of those with pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD), and other lung conditions, according to a study.
Reducing heart failure in pulmonary hypertension
An article published in Experimental Biology and Medicine (Volume 242, Issue 5, March, 2017) identifies a new signaling pathway that promotes heart failure in pulmonary hypertension. The study, led by Dr. Matthias Brock, from the Division of Pulmonology, University Hospital of Zurich, University of Zurich in Switzerland, reports that inhibition of MALAT1, a long noncoding RNA, reduces heart hypertrophy in mice with pulmonary hypertension.
Actelion obtains “Epoprostenol Act” label extension for pediatric PAH patients in Japan
Actelion (SIX: ATLN) announced today that Japan's Ministry of Health, Labor and Welfare granted a label extension for dosage and administration for "Epoprostenol ACT" (0.5 mg and 1.5 mg) for the treatment of pediatric patients with pulmonary arterial hypertension (PAH).
Recent News


Get the latest on PH treatments, community events and more when you subscribe to our newsletter